NFKB1 and leukemia: It had been shown that suppression of NF-kB activation to enhance chemosensitivity by imidazoline in leukemia T cells responsive to camptothecin [35] or by curcumin in esophageal adenocarcinoma responsive to 5-fluorouracil or cisplatin [36].